Cargando…

Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism

ABSTRACT: Liver fibrosis is a chronic liver disease with the presence of progressive wound healing response caused by liver injury. Currently, there are no approved therapies for liver fibrosis. Exosomes derived from human adipose mesenchymal stem cells (hADMSCs-Exo) have displayed a prominent thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zilong, Shang, Jin, Yang, Qinyan, Dai, Zonglin, Liang, Yuxin, Lai, Chunyou, Feng, Tianhang, Zhong, Deyuan, Zou, Haibo, Sun, Lelin, Su, Yuhao, Yan, Su, Chen, Jie, Yao, Yutong, Shi, Ying, Huang, Xiaolun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878808/
https://www.ncbi.nlm.nih.gov/pubmed/36698192
http://dx.doi.org/10.1186/s12951-023-01788-4
_version_ 1784878567970045952
author Zhang, Zilong
Shang, Jin
Yang, Qinyan
Dai, Zonglin
Liang, Yuxin
Lai, Chunyou
Feng, Tianhang
Zhong, Deyuan
Zou, Haibo
Sun, Lelin
Su, Yuhao
Yan, Su
Chen, Jie
Yao, Yutong
Shi, Ying
Huang, Xiaolun
author_facet Zhang, Zilong
Shang, Jin
Yang, Qinyan
Dai, Zonglin
Liang, Yuxin
Lai, Chunyou
Feng, Tianhang
Zhong, Deyuan
Zou, Haibo
Sun, Lelin
Su, Yuhao
Yan, Su
Chen, Jie
Yao, Yutong
Shi, Ying
Huang, Xiaolun
author_sort Zhang, Zilong
collection PubMed
description ABSTRACT: Liver fibrosis is a chronic liver disease with the presence of progressive wound healing response caused by liver injury. Currently, there are no approved therapies for liver fibrosis. Exosomes derived from human adipose mesenchymal stem cells (hADMSCs-Exo) have displayed a prominent therapeutic effect on liver diseases. However, few studies have evaluated therapeutic effect of hADMSCs-Exo in liver fibrosis and cirrhosis, and its precise mechanisms of action remain unclear. Herein, we investigated anti-fibrotic efficacy of hADMSCs-Exo in vitro and in vivo, and identified important metabolic changes and the detailed mechanism through transcriptomic and metabolomic profiling. We found hADMSCs-Exo could inhibit the proliferation of activated hepatic stellate cells through aggravating apoptosis and arresting G1 phase, effectively inhibiting the expression of profibrogenic proteins and epithelial-to-mesenchymal transition (EMT) in vitro. Moreover, it could significantly block collagen deposition and EMT process, improve liver function and reduce liver inflammation in liver cirrhosis mice model. The omics analysis revealed that the key mechanism of hADMSCs-Exo anti-hepatic fibrosis was the inhibition of PI3K/AKT/mTOR signaling pathway and affecting the changes of metabolites in lipid metabolism, and mainly regulating choline metabolism. CHPT1 activated by hADMSCs-Exo facilitated formation and maintenance of vesicular membranes. Thus, our study indicates that hADMSCs-Exo can attenuate hepatic stellate cell activation and suppress the progression of liver fibrosis, which holds the significant potential of hADMSCs-Exo for use as extracellular nanovesicles-based therapeutics in the treatment of liver fibrosis and possibly other intractable chronic liver diseases. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-023-01788-4.
format Online
Article
Text
id pubmed-9878808
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98788082023-01-27 Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism Zhang, Zilong Shang, Jin Yang, Qinyan Dai, Zonglin Liang, Yuxin Lai, Chunyou Feng, Tianhang Zhong, Deyuan Zou, Haibo Sun, Lelin Su, Yuhao Yan, Su Chen, Jie Yao, Yutong Shi, Ying Huang, Xiaolun J Nanobiotechnology Research ABSTRACT: Liver fibrosis is a chronic liver disease with the presence of progressive wound healing response caused by liver injury. Currently, there are no approved therapies for liver fibrosis. Exosomes derived from human adipose mesenchymal stem cells (hADMSCs-Exo) have displayed a prominent therapeutic effect on liver diseases. However, few studies have evaluated therapeutic effect of hADMSCs-Exo in liver fibrosis and cirrhosis, and its precise mechanisms of action remain unclear. Herein, we investigated anti-fibrotic efficacy of hADMSCs-Exo in vitro and in vivo, and identified important metabolic changes and the detailed mechanism through transcriptomic and metabolomic profiling. We found hADMSCs-Exo could inhibit the proliferation of activated hepatic stellate cells through aggravating apoptosis and arresting G1 phase, effectively inhibiting the expression of profibrogenic proteins and epithelial-to-mesenchymal transition (EMT) in vitro. Moreover, it could significantly block collagen deposition and EMT process, improve liver function and reduce liver inflammation in liver cirrhosis mice model. The omics analysis revealed that the key mechanism of hADMSCs-Exo anti-hepatic fibrosis was the inhibition of PI3K/AKT/mTOR signaling pathway and affecting the changes of metabolites in lipid metabolism, and mainly regulating choline metabolism. CHPT1 activated by hADMSCs-Exo facilitated formation and maintenance of vesicular membranes. Thus, our study indicates that hADMSCs-Exo can attenuate hepatic stellate cell activation and suppress the progression of liver fibrosis, which holds the significant potential of hADMSCs-Exo for use as extracellular nanovesicles-based therapeutics in the treatment of liver fibrosis and possibly other intractable chronic liver diseases. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-023-01788-4. BioMed Central 2023-01-25 /pmc/articles/PMC9878808/ /pubmed/36698192 http://dx.doi.org/10.1186/s12951-023-01788-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Zilong
Shang, Jin
Yang, Qinyan
Dai, Zonglin
Liang, Yuxin
Lai, Chunyou
Feng, Tianhang
Zhong, Deyuan
Zou, Haibo
Sun, Lelin
Su, Yuhao
Yan, Su
Chen, Jie
Yao, Yutong
Shi, Ying
Huang, Xiaolun
Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism
title Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism
title_full Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism
title_fullStr Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism
title_full_unstemmed Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism
title_short Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism
title_sort exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting pi3k/akt/mtor pathway and remodeling choline metabolism
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878808/
https://www.ncbi.nlm.nih.gov/pubmed/36698192
http://dx.doi.org/10.1186/s12951-023-01788-4
work_keys_str_mv AT zhangzilong exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT shangjin exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT yangqinyan exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT daizonglin exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT liangyuxin exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT laichunyou exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT fengtianhang exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT zhongdeyuan exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT zouhaibo exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT sunlelin exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT suyuhao exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT yansu exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT chenjie exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT yaoyutong exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT shiying exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism
AT huangxiaolun exosomesderivedfromhumanadiposemesenchymalstemcellsamelioratehepaticfibrosisbyinhibitingpi3kaktmtorpathwayandremodelingcholinemetabolism